4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-061710
General Counsel and Secretary sold 2,112 shares at $52.58 ($111,049)
- General Counsel and Secretary acquired 3,825 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KASINGER JAMES R. · General Counsel and Secretary
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-18 | Exercise or conversion : show line 1 in the form | +3,825 | 87,227 | D | ||
| 2026-02-19 | Sale : show line 2 in the form | −2,112 | $52.58 | $111,049 | 85,115 | D |
| Open-market sales · 2,112 sh · avg $52.58 · $111,049 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-18 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −3,825 | 0 | D |
Loading xslF345X05/ownership.xml…